Creative Medical Technology to Showcase CaverStem® at American Urological Association Annual Meeting - Largest and Most Prominent Gathering of Urologists in the World

About this update from Creative Medical Technology Holdings, Inc.

[{"type":"text","content":"PHOENIX, April 12, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (\"Creative Medical Technology\" or the \"Company\") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology and orthopedics, today announced that it will be exhibiting at the American Urological Association (\"AUA\") Annual Meeting on May 13-16, 2022 in New Orleans to showcase CaverStem®, the only patented procedure performed by a licensed physician that provides a safe, effective solution to treat erectile dysfunction using the patient's own stem cells to repair damaged tissue.\n\n \n \n \n \n \n \n\n \n\"With the addition of team members with decades of experience in medicine and medical marketing, we are excited to present CaverStem® to this very prominent group of practicing physicians. CaverStem® is backed by clinical trial results published in a peer reviewed journal and supported by testimonials from patients that have had life-changing positive results,\" said Timothy Warbington, President and CEO of Creative Medical Technology.\nNotable accomplishments:\nLandmark clinical trial results published in Journal of Translational Medicine showing strong efficacy and no major adverse effects (Link)Protocol optimized to eliminate the need for centrifuge – reducing capital equipment cost and streamlining the procedure for providers and patientsExclusive rights for the use of the FDA approved deviceExpanding physician network – validation not only of the technology, but the lucrative business modelConsumer awareness programs optimized to support healthcare providers with outreachThe Company's presenters at the conference will include Dr. Naveen Kella from The Urology Place (www.TheUrologyPlace.com), who has successfully performed over 50 procedures at his San Antonio, TX location. Dr. Kella will share his experience from training to the ongoing support he receives from Creative Medical Technology and the impact it has had on his practice and patients.\n\"We initially read the study on CaverStem® and after talking to other providers were encouraged about this technology. I am excited to present my own experience with this treatment for which we are collecting data on outcomes,\" said Dr. Kella.\nThe Company plans to utilize the AUA event to share updated data on CaverSt...

More updates from Creative Medical Technology Holdings, Inc.